0.3946
price up icon2.97%   0.0114
pre-market  Pre-market:  .39   -0.0046   -1.17%
loading
Reshape Lifesciences Inc stock is traded at $0.3946, with a volume of 9.82M. It is up +2.97% in the last 24 hours and down -40.57% over the past month. Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
See More
Previous Close:
$0.3832
Open:
$0.3943
24h Volume:
9.82M
Relative Volume:
0.69
Market Cap:
$4.28M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.0102
EPS:
-38.77
Net Cash Flow:
$-17.45M
1W Performance:
+3.84%
1M Performance:
-40.57%
6M Performance:
-93.37%
1Y Performance:
-95.92%
1-Day Range:
Value
$0.37
$0.436
1-Week Range:
Value
$0.3016
$0.4925
52-Week Range:
Value
$0.30
$29.00

Reshape Lifesciences Inc Stock (RSLS) Company Profile

Name
Name
Reshape Lifesciences Inc
Name
Phone
949-429-6680
Name
Address
1001 CALLE AMANECER, SAN CLEMENTE
Name
Employee
18
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
RSLS's Discussions on Twitter

Compare RSLS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
RSLS
Reshape Lifesciences Inc
0.3946 4.28M 9.81M -26.16M -17.45M -38.77
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Reshape Lifesciences Inc Stock (RSLS) Latest News

pulisher
Apr 22, 2025

Insider Sale Alert: ReShape Lifesciences Inc [RSLS] – Is it Time to sell? - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

ReShape Lifesciences Ignites Retail Frenzy As Stock Soars On US Patent For Diabetes Neuromodulation System - MSN

Apr 22, 2025
pulisher
Apr 21, 2025

ReShape Shares Soar After USPTO's Notice of Allowance for Diabetes Neuromodulation Patent - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

ReShape Lifesciences secures patent for diabetes treatment By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

ReShape Lifesciences Gets USPTO's Notice of Allowance for Diabetes Neuromodulation Patent - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

ReShape Lifesciences (RSLS) Gains on Diabetes Neuromodulation Patent News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

ReShape Lifesciences secures patent for diabetes treatment - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

ReShape Lifesciences® Receives Notice of Allowance for - GlobeNewswire

Apr 21, 2025
pulisher
Apr 21, 2025

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology - Yahoo

Apr 21, 2025
pulisher
Apr 14, 2025

ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Why Did ReShape Lifesciences Plunge 11.04%? Earnings Miss, Bearish Sentiment - AInvest

Apr 14, 2025
pulisher
Apr 12, 2025

Earnings call transcript: ReShape Lifesciences Q1 2024 sees cost cuts amid revenue drop - Investing.com UK

Apr 12, 2025
pulisher
Apr 11, 2025

Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga

Apr 11, 2025
pulisher
Apr 10, 2025

ReShape Lifesciences Reports 2024 Financial Results and Strategic Updates - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Earnings call transcript: ReShape Lifesciences Q1 2024 sees cost cuts amid revenue drop By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

ReShape Lifesciences Shares Surge 82.2% After Partnership Announcement - AInvest

Apr 10, 2025
pulisher
Apr 10, 2025

Dow Tumbles Over 800 Points; US Inflation Rate Falls In March - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

Penny Stock ReShape To Distribute FDA-Cleared Neuromuscular Device In US - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights 'Fairly Weak Returns' After 5%+ Gains In S&P 500 - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 10, 2025
pulisher
Apr 09, 2025

ReShape secures exclusive deal for neuromuscular rehab tech By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

ReShape Lifesciences to Bring Motion Informatics' Neuromuscular Rehabilitation Devices to US - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

ReShape secures exclusive deal for neuromuscular rehab tech - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market - The Manila Times

Apr 09, 2025
pulisher
Apr 09, 2025

ReShape Lifesciences® Partners with Motion Informatics to - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

AI Breakthrough: ReShape Brings Next-Gen Neuro Rehabilitation Platform to US Healthcare - Stock Titan

Apr 09, 2025
pulisher
Apr 09, 2025

RSLS stock touches 52-week low at $0.34 amid market challenges - Investing.com India

Apr 09, 2025
pulisher
Apr 07, 2025

ReShape Lifesciences Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Apr 07, 2025
pulisher
Apr 04, 2025

ReShape Lifesciences Inc. SEC 10-K Report - TradingView

Apr 04, 2025
pulisher
Apr 04, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Apr 04, 2025
pulisher
Apr 02, 2025

ReShape Lifesciences shareholders approve key proposals By Investing.com - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Nasdaq Tumbles 100 Points; UniFirst Posts Upbeat Earnings - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews

Apr 02, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

ReShape Lifesciences shareholders approve key proposals - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Stock Market News For Apr 2, 2025 - Yahoo Finance

Apr 02, 2025
pulisher
Apr 01, 2025

ReShape Lifesciences Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside - The Globe and Mail

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Global Bariatric Surgeries Market to Hit USD 27.64 Billion - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Nueva Network Launches Que-Onnda Radio in Washington DC & Boston - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Frazier Life Sciences Welcomes Chris Aakre as Principal of Company Creation - Yahoo Finance

Apr 01, 2025

Reshape Lifesciences Inc Stock (RSLS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Cap:     |  Volume (24h):